Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
424 studies found for:    "tetrasomy 18p" OR "Chromosomal Disorder"
Show Display Options
Rank Status Study
21 Completed Genetic Analysis of Fraser Syndrome and Fryns Syndrome
Conditions: Fraser Syndrome;   Fryns Syndrome;   Chromosomal Abnormalities;   Abnormalities, Multiple
Intervention:
22 Terminated Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Conditions: Acute Myeloid Leukemia (AML);   Acute Promyelocytic Leukemia (APL);   Refractory Anemia With Excess of Blasts (RAEB)
Intervention:
23 Unknown  Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test
Condition: Post-natal Cytogenetics
Intervention:
24 Completed Azacytidine for the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML) With High Risk (Chromosome 7 and or Complex) Cytogenetic Abnormalities
Conditions: Myelodysplastic Syndromes;   Leukemia, Myeloid, Acute
Intervention: Drug: 5 azacytidine
25 Completed
Has Results
Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality
Condition: Myelodysplastic Syndromes
Intervention: Drug: lenalidomide
26 Completed Melatonin Levels in Smith Magenis Syndrome (SMS)
Condition: Chromosome Disorders
Interventions: Dietary Supplement: Melatonin;   Device: Enviro-light artificial light box
27 Completed Evaluation of Patients With Unresolved Chromosome Abnormalities
Conditions: Abnormalities;   Failure to Thrive;   Mental Retardation;   Microcephaly
Intervention:
28 Terminated Relationship of Genetic Differences to the Development of Chromosome Abnormalities
Condition: Radiation Exposure
Intervention:
29 Recruiting Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)
Conditions: 22q13 Deletion Syndrome;   Phelan-McDermid Syndrome
Interventions: Drug: Insulin-Like Growth Factor-1 (IGF-1);   Drug: Normal saline
30 Active, not recruiting Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment
Condition: Phelan-McDermid Syndrome
Intervention:
31 Recruiting Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome
Conditions: Klinefelter Syndrome;   XXY Syndrome
Interventions: Drug: Testosterone gel 1%;   Drug: Placebo gel
32 Recruiting Non-Invasive Chromosomal Evaluation of Trisomy Study
Conditions: Aneuploidy;   Trisomy 21;   Trisomy 18;   Trisomy 13;   Down Syndrome
Intervention:
33 Completed
Has Results
Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Extended Release Methylphenidate (Ritalin LA ) plus Behavior Therapy;   Behavioral: Behavior Therapy
34 Completed
Has Results
Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality
Condition: Myelodysplastic Syndromes
Interventions: Drug: Lenalidomide 5 mg;   Drug: Lenalidomide 10 mg;   Drug: Placebo
35 Completed Non-Invasive Screening for Fetal Aneuploidy
Conditions: Down Syndrome;   Edwards Syndrome
Intervention: Other: Maternal blood screening test for fetal aneuploidy
36 Recruiting X-chromosome Inactivation, Epigenetics and the Transcriptome
Conditions: Turner Syndrome;   Klinefelter Syndrome;   Triple X Syndrome;   47 XYY Syndrome;   Aortic Aneurysm
Intervention:
37 Completed Androgen for Leydig Cell Proliferation
Conditions: Klinefelter Syndrome;   Hypergonadotropic Hypogonadism;   Hypergonadotropic Azospermia;   Hypergonadotropic Cryptozoospermia
Interventions: Drug: Testosterone undecanoate;   Drug: Castor Oil
38 Unknown  Long Term Follow-up of Bone Mineral Density in Hormone Treated Turner Syndrome
Condition: Turner Syndrome
Intervention:
39 Recruiting A Clinical Study to Assess the Efficacy and Safety of DA-3002
Condition: Turner's Syndrome
Interventions: Drug: DA-3002;   Drug: Genotropin®
40 Recruiting Effect of Testosterone Treatment on Embryo Quality
Conditions: Primary Ovarian Insufficiency;   Female Infertility Due to Diminished Ovarian Reserve
Interventions: Drug: Testosterone cream (0.5mg per gram);   Dietary Supplement: DHEA;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years